A Big Alzheimer’s Drug Study Is Proceeding Cautiously, Despite The Pandemic
(By Jon Hamilton for NPR) Medical research was an early casualty of the COVID-19 pandemic. After cases began emerging worldwide,
Read More(By Jon Hamilton for NPR) Medical research was an early casualty of the COVID-19 pandemic. After cases began emerging worldwide,
Read MoreA VA pilot study found that a brain stimulation therapy provided to patients with Alzheimer’s disease improved their state of
Read MoreA team from Stevens Institute of Technology has designed an explainable AI tool that uses attention mechanisms and a convolutional
Read More(Source – www.nia.nih.gov/news) With the aging of the U.S. population, the incidence of Alzheimer’s disease continues to rise. The disease
Read More( By Heidi de Marco for Kaiser Health News) GARDENA, Calif. — Daisy Conant, 91, thrives off routine. One of her
Read More(By Adam Feuerstein for STAT) The Food and Drug Administration has agreed to review a marketing application submitted by Biogen
Read MoreThe results from a $100 million study of more than 25,000 Medicare recipients will help Medicare officials decide whether to
Read MoreThe Alzheimer’s Association finds nearly six million people in the United States have Alzheimer’s and their ranks are expected to
Read More(By Jon Hamilton for NPR) For years, public health officials have been trying to dispel the myth that people who get a
Read More(By Judith Graham for Kaiser Health News) Family gatherings on Zoom and FaceTime. Online orders from grocery stores and pharmacies.
Read More